{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:12:41Z","timestamp":1790770361133,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.parkreldis.2020.06.016","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T12:28:27Z","timestamp":1592915307000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Medical management of myoclonus-dystonia and implications for underlying pathophysiology"],"prefix":"10.1016","volume":"77","author":[{"given":"Conor","family":"Fearon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Peall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vidailhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2020.06.016_bib1","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/01.wnl.0000297516.98574.c0","article-title":"Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations","volume":"70","author":"Roze","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib2","first-page":"825","volume":"33","author":"Obeso","year":"1983","journal-title":"Myocl. dystonia Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.10325","article-title":"Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype","volume":"52","author":"Asmus","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.22425","article-title":"Myoclonus-dystonia: an update","volume":"24","author":"Kinugawa","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/brain\/aws308","article-title":"SGCE mutations cause psychiatric disorders: clinical and genetic characterization","volume":"136","author":"Peall","year":"2013","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng709","article-title":"Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome","volume":"29","author":"Zimprich","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib7","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/mds.27117","article-title":"Low CSF 5-HIAA in myoclonus dystonia","volume":"32","author":"Peall","year":"2017","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jb\/mvj138","article-title":"Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice","volume":"140","author":"Yokoi","year":"2006","journal-title":"J. Biochem. (Tokyo)."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00259-008-0924-9","article-title":"Reduced striatal D2 receptor binding in myoclonus-dystonia","volume":"36","author":"Beukers","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/WCO.0000000000000577","article-title":"Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment","volume":"31","author":"Roze","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.25326","article-title":"Surgical treatment of myoclonus dystonia syndrome","volume":"28","author":"Rughani","year":"2013","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.26215","article-title":"Pallidal stimulation for myoclonus-dystonia: ten years' outcome in two patients","volume":"30","author":"Roze","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ana.25035","article-title":"Alcohol improves cerebellar learning deficit in myoclonus-dystonia: a clinical and electrophysiological investigation","volume":"82","author":"Weissbach","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib14","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/mds.27822","article-title":"Twenty years on: myoclonus-dystonia and \u03b5-sarcoglycan \u2014 neurodevelopment, channel, and signaling dysfunction","volume":"34","author":"Menozzi","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10048-017-0510-z","article-title":"ADCY5-related dyskinesia presenting as familial myoclonus-dystonia","volume":"18","author":"Douglas","year":"2017","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib16","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.25802","article-title":"The phenotypic spectrum of DYT24 due to ANO3 mutations","volume":"29","author":"Stamelou","year":"2014","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1212\/WNL.59.8.1241","article-title":"Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome","volume":"59","author":"Leuzzi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2015.12.012","article-title":"Novel GNAL mutation with intra-familial clinical heterogeneity: expanding the phenotype","volume":"23","author":"Carecchio","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/mds.27708","article-title":"Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation","volume":"34","author":"Jones","year":"2019","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parkreldis.2019.01.004","article-title":"Childhood onset progressive myoclonic dystonia due to a de novo KCTD17 splicing mutation","volume":"61","author":"Marc\u00e9-Grau","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib21","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/mds.21692","article-title":"Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia","volume":"22","author":"Asmus","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.parkreldis.2009.10.008","article-title":"Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia","volume":"16","author":"Foncke","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.0b013e318261714a","article-title":"Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency","volume":"79","author":"Stamelou","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mds.10026","article-title":"Myoclonic dystonia as unique presentation of isolated vitamin E deficiency in a young patient","volume":"17","author":"Angelini","year":"2002","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000479788","article-title":"TUBB2B mutation in an adult patient with myoclonus-dystonia","volume":"9","author":"Geiger","year":"2017","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2016.00072","article-title":"Distribution and coexistence of myoclonus and dystonia as clinical predictors of sgce mutation status: a pilot study","volume":"7","author":"Zutt","year":"2016","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.parkreldis.2018.12.001","article-title":"A novel KCTD17 mutation is associated with childhood early-onset hyperkinetic movement disorder","volume":"61","author":"Graziola","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib28","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/WNL.0000000000002631","article-title":"A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia","volume":"86","author":"Hainque","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib29","article-title":"The potential roles of T-type Ca2+ channels in motor coordination","volume":"7","author":"Park","year":"2013","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fncel.2013.00230","article-title":"Signal processing by T-type calcium channel interactions in the cerebellum","volume":"7","author":"Engbers","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib31","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/mds.21674","article-title":"Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene","volume":"22","author":"Orth","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mds.21715","article-title":"Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families","volume":"23","author":"Nardocci","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jnnp.2003.027177","article-title":"Genetic heterogeneity in ten families with myoclonus-dystonia","volume":"75","author":"Sch\u00fcle","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870060308","article-title":"Hereditary essential myoclonus in a large Norwegian family","volume":"6","author":"Fahn","year":"1991","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejpn.2008.11.009","article-title":"Myoclonus in fraternal twin toddlers: a French family with a novel mutation in the SGCE gene","volume":"13","author":"Th\u00fcmmler","year":"2009","journal-title":"Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib36","series-title":"Myoclonus-Dystonia","author":"Raymond","year":"1993"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.parkreldis.2004.07.010","article-title":"Limited efficacy of levetiracetam on myoclonus of different etiologies","volume":"11","author":"Lim","year":"2005","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.parkreldis.2018.05.005","article-title":"Treatment of myoclonus-dystonia with carbamazepine","volume":"53","author":"Sanjari Moghaddam","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1528-1157.1991.tb05255.x","article-title":"Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine","volume":"32","author":"Dhuna","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib40","first-page":"188","article-title":"Treatment of myoclonus","volume":"11","author":"Caviness","year":"2014","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1528-1157.1986.tb03579.x","article-title":"Effect of carbamazepine on dopamine release and reuptake in rat striatal slices","volume":"27","author":"Barros","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00965147","article-title":"Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine","volume":"19","author":"Baf","year":"1994","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1212\/WNL.41.2_Part_1.174","article-title":"Dopa-responsive dystonia: long-term treatment response and prognosis","volume":"41","author":"Nygaard","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870110202","article-title":"Essential myoclonus and myoclonic dystonia","volume":"11","author":"Quinn","year":"1996","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0733-8619(05)70009-8","article-title":"Treatment of tremor and dystonia","volume":"19","author":"Goetz","year":"2001","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib46","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/mds.22745","article-title":"Excellent response to oral zolpidem in a sporadic case of the myoclonus dystonia syndrome","volume":"24","author":"Park","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00002826-198406000-00004","article-title":"Essential myoclonus: response to anticholinergic therapy","volume":"7","author":"Duvoisin","year":"1984","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib48","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1212\/WNL.37.4.608","article-title":"A physiologic and pharmacologic study in anticholinergic-responsive essential myoclonus","volume":"37","author":"Chokroverty","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3988\/jcn.2011.7.4.231","article-title":"A patient with genetically confirmed myoclonus-dystonia responded to anticholinergic treatment and improved spontaneously","volume":"7","author":"Lee","year":"2011","journal-title":"J. Clin. Neurol. Seoul Kor."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib50","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.26009","article-title":"Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors","volume":"29","author":"Maltese","year":"2014","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/hmg\/ddl472","article-title":"SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA","volume":"16","author":"Esapa","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib52","article-title":"Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib53","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.parkreldis.2014.09.029","article-title":"Treatment of myoclonus-dystonia syndrome with tetrabenazine","volume":"20","author":"Luciano","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/0972-2327.168625","article-title":"Sporadic and familial myoclonic dystonia: report of three cases and review of literature","volume":"19","author":"Bhattacharyya","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0022-510X(75)90165-3","article-title":"Tardive dyskinesia treated with pimozide","volume":"24","author":"Claveria","year":"1975","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/mds.22375","article-title":"Responsiveness to levodopa in epsilon-sarcoglycan deletions","volume":"24","author":"Luciano","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/mds.21785","article-title":"Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations","volume":"23","author":"Raymond","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib58","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/01.WNL.0000061480.86610.BF","article-title":"A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome","volume":"60","author":"Hjermind","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib59","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1531-8249(199911)46:5<794::AID-ANA19>3.0.CO;2-2","article-title":"Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31","volume":"46","author":"Nygaard","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/mds.10635","article-title":"Clinical and genetic features of myoclonus-dystonia in 3 cases: a video presentation","volume":"19","author":"Kock","year":"2004","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ejhg.2010.206","article-title":"SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?","volume":"19","author":"Ritz","year":"2011","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib62","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e31827f0798","article-title":"Metabolic changes in DYT11 myoclonus-dystonia","volume":"80","author":"Carbon","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamaneurol.2014.99","article-title":"The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias","volume":"71","author":"Popa","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib64","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41583-018-0002-7","article-title":"The basal ganglia and the cerebellum: nodes in an integrated network","volume":"19","author":"Bostan","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib65","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cne.20377","article-title":"Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain","volume":"482","author":"Chan","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/brain\/100.3.455","article-title":"Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam","volume":"100","author":"Chadwick","year":"1977","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00313626","article-title":"Essential familial myoclonus","volume":"230","author":"Przuntek","year":"1983","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib68","first-page":"107","article-title":"L-5-hydroxytryptophan therapy in myoclonus","volume":"26","author":"Van Woert","year":"1979","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib69","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s001150050673","article-title":"[Familial myoclonus-dystonia syndrome associated with panic attacks]","volume":"71","author":"Scheidtmann","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib70","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0006-3223(94)91215-7","article-title":"Serotonin and alcohol intake, abuse, and dependence: findings of animal studies","volume":"36","author":"LeMarquand","year":"1994","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib71","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/mds.20605","article-title":"A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders","volume":"20","author":"Frucht","year":"2005","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib72","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1212\/WNL.54.8.1706","article-title":"gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia","volume":"54","author":"Priori","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11940-016-0404-7","article-title":"Myoclonus: pathophysiology and treatment options","volume":"18","author":"Levy","year":"2016","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib74","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.0000000000004182","article-title":"Myoclonic dystonia (DYT11) responsive to insulin therapy: a case report","volume":"89","author":"Gazzina","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mdc3.12611","article-title":"Glucagon\u2010like peptides (GLP\u20101) perspectives in synucleinopathies treatment","volume":"5","author":"Foltynie","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","volume":"4","author":"Balint","year":"2018","journal-title":"Dystonia, Nat. Rev. Dis. Primer."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib77","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/mds.1119","article-title":"Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome","volume":"16","author":"Trottenberg","year":"2001","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib78","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/mds.20030","article-title":"Deep brain stimulation in myoclonus-dystonia syndrome","volume":"19","author":"Cif","year":"2004","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib79","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/jnnp.2004.039248","article-title":"Pallidal stimulation relieves myoclonus-dystonia syndrome","volume":"76","author":"Magari\u00f1os-Ascone","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib80","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.parkreldis.2014.04.017","article-title":"Bilateral pallidal stimulation for sargoglycan epsilon negative myoclonus","volume":"20","author":"Sidiropoulos","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib81","article-title":"Deep brain stimulation for myoclonus dystonia syndrome: a meta-analysis with individual patient data","author":"Wang","year":"2020","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib82","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1016\/j.wneu.2018.10.177","article-title":"Thalamus stimulation for myoclonus dystonia syndrome: five cases and long-term follow-up","volume":"122","author":"Zhang","year":"2019","journal-title":"World Neurosurg."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib83","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3171\/2009.10.JNS091062","article-title":"Both thalamic and pallidal deep brain stimulation for myoclonic dystonia","volume":"112","author":"Oropilla","year":"2010","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mds.27474","article-title":"Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment","volume":"34","author":"Kosutzka","year":"2019","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib85","first-page":"1947962","article-title":"Psychiatric and behavioral complications of GPi DBS in an adolescent with myoclonus dystonia","author":"Kriegel","year":"2019","journal-title":"Case Rep. Psychiatr."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib86","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archneurol.2011.180","article-title":"Effect of pallidal deep brain stimulation on psychiatric symptoms in myoclonus-dystonia due to \u03b5-sarcoglycan mutations","volume":"68","author":"Contarino","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/acn3.263","article-title":"Psychiatric disorders, myoclonus dystonia and SGCE: an international study","volume":"3","author":"Peall","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28033","article-title":"Natural course of myoclonus-dystonia in adulthood: stable motor signs but increased psychiatry","author":"Timmers","year":"2020","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib89","series-title":"Obsessive-Compulsive Disorder and Body Dysmorphic Disorder: Treatment. CG31","author":"National Institute for Health and Care Excellence","year":"2005"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib90","series-title":"Generalised Anxiety Disorder and Panic Disorder in Adults: Management","author":"National Institute for Health and Care Excellence","year":"2011"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib91","series-title":"Depression in Adults: Recognition and Management","author":"National Institute for Health and Care Excellence","year":"2009"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib92","first-page":"5","article-title":"American Psychiatric Association, Practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Koran","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib93","first-page":"1","article-title":"Practice guideline for the treatment of patients with panic disorder. Work group on panic disorder. American psychiatric association","volume":"155","year":"1998","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib94","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder (revision)","volume":"157","year":"2000","journal-title":"Am. Psychiatr. Assoc. Am. J. Psychiatr."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib95","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2017.08.007","article-title":"Abnormal striatal plasticity in a DYT11\/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition","volume":"108","author":"Maltese","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib96","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2010.03.003","article-title":"Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia","volume":"38","author":"Napolitano","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib97","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1212\/WNL.0000000000002058","article-title":"ADCY5-related dyskinesia: broader spectrum and genotype-phenotype correlations","volume":"85","author":"Chen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib98","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/mds.26598","article-title":"Phenotypic insights into ADCY5\u2010associated disease","volume":"31","author":"Chang","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib99","doi-asserted-by":"crossref","first-page":"13592","DOI":"10.1073\/pnas.1817689116","article-title":"Role of cerebellar GABAergic dysfunctions in the origins of essential tremor","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1756285616679123","article-title":"Emerging strategies in the management of essential tremor","volume":"10","author":"Hedera","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib101","first-page":"546","article-title":"Suppression of harmaline tremor by activation of an extrasynaptic GABAA receptor: implications for essential tremor","volume":"8","author":"Handforth","year":"2018","journal-title":"Tremor Hyperkinetic Mov. N. Y. N."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib102","first-page":"356","article-title":"Essential tremor: what we can learn from current pharmacotherapy","volume":"6","author":"Ondo","year":"2016","journal-title":"Tremor Hyperkinetic Mov. N. Y. N."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib103","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/0269881111415731","article-title":"The effects of TPA023, a GABAA\u03b12,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol","volume":"26","author":"de Haas","year":"2012","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib104","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI83621","article-title":"Dose-escalation study of octanoic acid in patients with essential tremor","volume":"126","author":"Voller","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib105","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/mds.25128","article-title":"White matter abnormalities in gene-positive myoclonus-dystonia","volume":"27","author":"van der Meer","year":"2012","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib106","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/mds.26244","article-title":"Pallidal activity in myoclonus dystonia correlates with motor signs","volume":"30","author":"Welter","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib107","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mds.21284","article-title":"Local field potentials and oscillatory activity of the internal globus pallidus in myoclonus-dystonia","volume":"22","author":"Foncke","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib108","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52101","article-title":"Acute cerebellar knockdown of Sgce reproduces salient features of myoclonus-dystonia (DYT11) in mice","volume":"8","author":"Washburn","year":"2019","journal-title":"ELife"},{"key":"10.1016\/j.parkreldis.2020.06.016_bib109","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ajhg.2015.04.008","article-title":"A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia","volume":"96","author":"Mencacci","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2020.06.016_bib110","first-page":"1225","volume":"19","author":"Morgante","year":"2013","journal-title":"Dystonia Contin. Minneap. Minn."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020301930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020301930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:18:36Z","timestamp":1761178716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020301930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":110,"alternative-id":["S1353802020301930"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.06.016","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical management of myoclonus-dystonia and implications for underlying pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}